Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19

<p>Delirium has been frequently found in patients who test positive for COVID-19. It has additional features that we do not typically see in ordinary delirium. The critical question is: How do you manage these patients?</p> <p>Guest: Scott Beach, M.D.<br /> Interviewer: Wegdan Rashad, M.D.<br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><strong><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC113"> Learn more about Premium Membership here</a></strong></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/neurocovid-pharmacological-recommendations-for-delirium-associated-with-covid-19-interview-2598?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC113"> <strong>Earn 0.5 CMEs: Neurocovid: Pharmacological recommendations for delirium associated with COVID-19 - Interview with Scott R. Beach, M.D.</strong></a></li> </ul> <p> </p>